Recurrent B Acute Lymphoblastic Leukemia Recruiting Phase 1 / 2 Trials for Prednisone acetate (DB14646)

IndicationStatusPhase
DBCOND0107328 (Recurrent B Acute Lymphoblastic Leukemia)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03808610Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic LeukemiaTreatment